For more than a decade, i2E (Innovation to Enterprise) has played a major role in funding Oklahoma researchers and entrepreneurs by investing more than $14.6 million in Oklahoma bioscience companies that are either developing new therapeutics, developing new medical devices or providing support technologies for research and development. In the past year, i2E Inc. has invested more than $1.9 million in five bioscience companies. Companies in the i2E portfolio are advancing a diverse mix of medical solutions for specific conditions that range from inflammatory disease to macular degeneration to antibiotics to food safety, hearing loss, toxicology and much more.
I2E has received national recognition from numerous national organizations including the Southern Growth Policies Board, Kauffman Foundation, International Economic Development Council, State Science & Technology Institute, Standards for Excellence Institute and the Regional Innovation Acceleration Network.
These sample images are available for download in high resolution .jpg format by registering and logging in. They are intended to be used for editorial purposes only.